Anticipated Shortage

DOXORUBICIN HYDROCHLORIDE FOR INJECTION USP

PFIZER CANADA ULC

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of DOXORUBICIN HYDROCHLORIDE FOR INJECTION USP in Canada?

A shortage of DOXORUBICIN HYDROCHLORIDE FOR INJECTION USP 150MG is expected: the manufacturer reported it to Health Canada as an anticipated shortage (last updated October 1, 2026), but it has not started yet.

Why is DOXORUBICIN HYDROCHLORIDE FOR INJECTION USP not available?

The reason the manufacturer reported: Disruption of the manufacture of the drug.

When will DOXORUBICIN HYDROCHLORIDE FOR INJECTION USP be available again?

The manufacturer's estimated resolution date is December 31, 2028. This is an estimate and can change; follow this page to get an email when the status changes.

Can I still get this?Check with your pharmacist — only products with a different form or route found

StatusAnticipated Shortage

Same-ingredient products on file2 products · 0 same form & route

Expected resolution~26 months remaining (estimate)

Affected strength150MG

Report last updated2026-10-01

Checked by MedShort2026-11-12

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Other Products

CAELYX

BAXTER CORPORATION

2MG · DIN 02238389

Different strengthDifferent dosage formSame routeNo current shortage

Compare these two →

TARO-DOXORUBICIN LIPOSOMAL

TARO PHARMACEUTICALS INC

2MG · DIN 02493020

Different strengthDifferent dosage formSame routeNo current shortage

Compare these two →

What this means

Does this mean my pharmacy is already out of stock?

No — this shortage hasn't started yet. It's an early warning that supply may become tight, based on information from the manufacturer.

What should I do?

This product is usually given in a hospital or clinic, where the pharmacy team manages supply. If you're scheduled to receive it, ask your care team.

Estimated Resolution

2028-12-31

~26 months remaining (estimate)

This is the manufacturer's estimated date, not a guarantee — actual resolution may come earlier or later.

Have you checked a pharmacy recently?

No community reports yet — be the first to share what you found.

Community reports are not verified by a pharmacy and may reflect a small sample size. This is not a guarantee of current stock.

DIN

02194473

Strength

150MG

Dosage Form

POWDER FOR SOLUTION

Route

INTRAVESICAL INTRAVENOUS

Active Ingredient

DOXORUBICIN HYDROCHLORIDE

Tier

Unrated

Last Updated

2026-10-01

Reason for Shortage

Disruption of the manufacture of the drug.

Source

View original report on healthproductshortages.ca ↗

Other Products from PFIZER CANADA ULC

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

40MG · DIN 02511053

40MG · DIN 02511045

20MG · DIN 02511061

DIN 02544040

5MG · DIN 01947664

10MG · DIN 01947672